These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33617587)

  • 1. The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    Tokumitsu K; Yasui-Furukori N; Takeuchi J; Yachimori K; Sugawara N; Terayama Y; Tanaka N; Naraoka T; Shimoda K
    PLoS One; 2021; 16(2):e0247427. PubMed ID: 33617587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of brain perfusion single-photon emission tomography images using an easy Zscore imaging system for early diagnosis of Alzheimer's disease].
    Wang S; Qi Y; Jiang Y; Chi X; Huang K; Ruan C; Yang X; Li G
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1093-1100. PubMed ID: 34308862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparison with Chang's method.
    Sohara K; Kiriyama T; Mizumura S; Ishiwata A; Yamazaki M; Kimura K; Kumita SI
    Ann Nucl Med; 2020 Jul; 34(7):502-511. PubMed ID: 32449110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of combined analysis using CIScore and VSRAD parameters for differentiating between dementia with Lewy body and Alzheimer's disease.
    Honda G; Nagamachi S; Takahashi M; Higuma Y; Tani T; Hida K; Yoshimitsu K; Ogomori K; Tsuboi Y
    Jpn J Radiol; 2024 Oct; 42(10):1206-1212. PubMed ID: 38856880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?
    Pinto TCC; Machado L; Bulgacov TM; Rodrigues-Júnior AL; Costa MLG; Ximenes RCC; Sougey EB
    Int Psychogeriatr; 2019 Apr; 31(4):491-504. PubMed ID: 30426911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An easy Z-score imaging system for discrimination between very early Alzheimer's disease and controls using brain perfusion SPECT in a multicentre study.
    Matsuda H; Mizumura S; Nagao T; Ota T; Iizuka T; Nemoto K; Kimura M; Tateno A; Ishiwata A; Kuji I; Arai H; Homma A
    Nucl Med Commun; 2007 Mar; 28(3):199-205. PubMed ID: 17264779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the decreases in regional cerebral blood flow in the posterior cingulate cortex, precuneus, and parietal lobe between suspected non-Alzheimer's disease pathophysiology and Alzheimer's disease.
    Hayashi H; Kobayashi R; Kawakatsu S; Ohba M; Morioka D; Otani K
    Psychogeriatrics; 2021 Sep; 21(5):716-721. PubMed ID: 34101304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of 11C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease.
    Kitajima K; Abe K; Takeda M; Yoshikawa H; Ohigashi M; Osugi K; Koyama H; Yamakado K
    Medicine (Baltimore); 2021 Jan; 100(3):e23969. PubMed ID: 33545981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
    Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
    Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination ability of the Short Test of Mental Status (STMS) compared to the Mini Mental State Examination (MMSE) in the spectrum of normal cognition, mild cognitive impairment, and probable Alzheimer's disease dementia: The Turkish standardization study.
    Çebi M; Babacan G; Öktem Tanör Ö; Gürvit H
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):450-458. PubMed ID: 32406297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
    Takemaru M; Kimura N; Abe Y; Goto M; Matsubara E
    Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography.
    Matsuda H; Mizumura S; Nagao T; Ota T; Iizuka T; Nemoto K; Takemura N; Arai H; Homma A
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):731-6. PubMed ID: 17416830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia.
    Jannati A; Toro-Serey C; Gomes-Osman J; Banks R; Ciesla M; Showalter J; Bates D; Tobyne S; Pascual-Leone A
    Alzheimers Res Ther; 2024 Jan; 16(1):2. PubMed ID: 38167251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.